Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism

Wang,Xiaopeng; Zhao,Jing

doi:10.3892/mmr.2019.10835

Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism

Authors:
- Xiaopeng Wang
- Jing Zhao
View Affiliations

Affiliations: Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China
Published online on: November 20, 2019 https://doi.org/10.3892/mmr.2019.10835
Pages: 115-122
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder causing progressive memory loss and cognitive impairment. The aberrant accumulation of amyloid‑β (Aβ) and neuroinflammation are two major events in AD. Aβ‑induced neurotoxicity and oxidative stress are also involved in the pathogenesis of AD. The purpose of the current study was to investigate the effect of compound porcine cerebroside and ganglioside injection (CPCGI) on the progression of AD, and to explore the molecular mechanism. In vivo and in vitro models of AD were established and treated with CPCGI. Aβ40 and Aβ42 protein levels were detected using western blotting. Production of pro‑inflammatory factors [tumor necrosis factor (TNF)‑α and interleukin (IL)‑1β] and oxidative stress markers [malondialdehyde (MDA), superoxide dismutase (SOD)] and reactive oxygen species (ROS) production were determined. Cell viability and apoptosis were detected using 3‑(4,5‑dimethyl‑2‑thiazolyl)‑2,5‑diphenyl‑2‑H‑tetrazolium bromide assay and flow cytometry analysis respectively. Results demonstrated that CPCGI administration reduced Aβ40 and Aβ42 accumulation, and inhibited inflammatory response and oxidative stress in the in vivo rat model of AD, evidenced by decreased Aβ40 and Aβ42 protein expression, reduced levels of TNF‑α and IL‑1β, reduced MDA content, enhanced SOD activity, and reduced ROS level. It was found that CPCGI enhanced cell viability and reduced cell apoptosis of Aβ25‑35 induced PC12 cells. In addition, the mitogen‑activated protein kinase/NF‑κB pathway was involved in the protective effect of CPCGI on AD. Taken together, the data demonstrated that CPCGI exerted a protective effect on AD by reducing Aβ accumulation, inhibiting inflammatory response and oxidative stress, In addition to preventing neuronal apoptosis.

View Figures

View References

1	Selkoe DJ: Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev. 81:741–766. 2001. View Article : Google Scholar : PubMed/NCBI
2	Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, et al: Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurol. 6:734–746. 2007. View Article : Google Scholar : PubMed/NCBI
3	Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K and Müller-Hill B: The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:733–736. 1987. View Article : Google Scholar : PubMed/NCBI
4	Glenner GG and Wong CW: Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 120:885–890. 1984. View Article : Google Scholar : PubMed/NCBI
5	Lane CA, Hardy J and Schott JM: Alzheimer's disease. Eur J Neurol. 25:59–70. 2018. View Article : Google Scholar : PubMed/NCBI
6	Frost PS, Barros-Aragão F, da Silva RT, Venancio A, Matias I, Lyra E Silva NM, Kincheski GC, Pimentel-Coelho PM, De Felice FG, Gomes FCA, et al: Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice. Cell Death Dis. 10:3232019. View Article : Google Scholar : PubMed/NCBI
7	Blennow K, Leon MJD and Zetterberg H: Alzheimer's disease. Lancet. 368:387–403. 2006. View Article : Google Scholar : PubMed/NCBI
8	Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D and Jones E: Alzheimer's disease. Lancet. 377:1019–1031. 2011. View Article : Google Scholar : PubMed/NCBI
9	Teng E, Taylor K, Bilousova T, Weiland D, Pham T, Zuo X, Yang F, Chen PP, Glabe CG, Takacs A, et al: Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerization. Neurobiol Dis. 552–560. 2015. View Article : Google Scholar : PubMed/NCBI
10	Wang M, Zhang Y, Feng L, Zheng J, Fan S, Liu J, Yang N, Liu Y and Zuo P: Compound porcine cerebroside and ganglioside injection attenuates cerebral ischemia-reperfusion injury in rats by targeting multiple cellular processes. Neuropsychiatr Dis Treat. 13:927–935. 2017. View Article : Google Scholar : PubMed/NCBI
11	Wang M, Feng L, Fan S, Zheng JI, LI DM, Yang N, Zuo P and Liu Y: Effect of Compound porcine cerebroside and ganglioside injection on cerebral ischemia-reperfusion injury in rats. Chin J Rehabil Theory Prac. 281–285. 2016.
12	Kwak DH, Kim SM, Lee DH, Kim JS, Kim SM, Lee SU, Jung KY, Seo BB and Choo YK: Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion. Mol Cells. 20:354–360. 2005.PubMed/NCBI
13	Zamfir AD: Neurological analyses: Focus on gangliosides and mass spectrometry. Adv Exp Med Biol. 806:153–204. 2014. View Article : Google Scholar : PubMed/NCBI
14	Huang XF, Wang JM, Chen Q, Wei YY and Chen HW: Meta-analysis on effect of compound Danshen injection in treating neonatal hypoxic-ischemic encephalopathy. Zhongguo Zhong Yao Za Zhi. 40:141–148. 2015.(In Chinese). PubMed/NCBI
15	Wang H, Jiang HQ, Li J, et al: Clinical study of Compound Porcine Cerebroside and Ganglioside Injection on Alzheimer disease. Chinese Community doctors. 12:127–128. 2010.(In Chinese).
16	Bayne K: Revised guide for the care and use of laboratory animals available. American physiological society. Physiologist. 39(199): 208–211. 1996.
17	Amani M, Shokouhi G and Salari AA: Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer's disease. Psychopharmacology (Berl). 236:1281–1292. 2018. View Article : Google Scholar : PubMed/NCBI
18	Garcez ML, Mina F, Bellettini-Santos T, Carneiro FG, Luz AP, Schiavo GL, Andrighetti MS, Scheid MG, Bolfe RP and Budni J: Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1–42) in mice. Prog Neuropsychopharmacology Biol Psychiatry. 77:23–31. 2017. View Article : Google Scholar
19	Cioanca O, Hritcu L, Mihasan M, Trifan A and Hancianu M: Inhalation of coriander volatile oil increased anxiolytic-antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1–42) rat model of Alzheimer's disease. Physiol Behav. 131:68–74. 2014. View Article : Google Scholar : PubMed/NCBI
20	Sharifi AM and Mousavi SH: Studying the effects of lead on DNA fragmentation and proapoptotic bax and antiapoptotic Bcl-2 protein expression in PC12 cells. Toxicol Mech Methods. 18:55–79. 2008. View Article : Google Scholar
21	Lee S, Youn K, Kim DH, Ahn MR, Yoon E, Kim OY and Jun M: Anti-neuroinflammatory property of phlorotannins from Ecklonia cava on Aβ_25-35-induced damage in PC12 cells. Mar Drugs. 17:E72018. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Balin BJ and Hudson AP: Etiology and pathogenesis of late-onset Alzheimer's disease. Curr Allergy Asthma Rep. 14:4172014. View Article : Google Scholar : PubMed/NCBI
24	Area-Gomez E and Schon EA: On the pathogenesis of Alzheimer's disease: The MAM hypothesis. FASEB J. 31:864–867. 2017. View Article : Google Scholar : PubMed/NCBI
25	Bolós M, Perea JR and Avila J: Alzheimer's disease as an inflammatory disease. Biomol Concepts. 8:37–43. 2017. View Article : Google Scholar : PubMed/NCBI
26	Nazıroğlu M, Muhamad S and Pecze L: Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: Focus on selenium nanoparticles. Expert Rev Clin Pharmacol. 10:773–782. 2017. View Article : Google Scholar : PubMed/NCBI
27	Dastan Z, Pouramir M, Ghasemi-Kasman M, Ghasemzadeh Z, Dadgar M, Gol M, Ashrafpour M, Pourghasem M, Moghadamnia AA and Khafri S: Arbutin reduces cognitive deficit and oxidative stress in animal model of Alzheimer's disease. Int J Neurosci. 129:1145–1153. 2019. View Article : Google Scholar : PubMed/NCBI
28	Faux NG, Ellis KA, Porter L, Fowler CJ, Laws SM, Martins RN, Pertile KK, Rembach A, Rowe CC, Rumble RL, et al: Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: Baseline characteristics in subjects of the Australian imaging biomarker lifestyle study. J Alzheimers Dis. 27:909–922. 2011. View Article : Google Scholar : PubMed/NCBI
29	Connelly PJ, Prentice NP, Cousland G and Bonham J: A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease. Int J Geriatr Psychiatry. 23:155–160. 2010. View Article : Google Scholar
30	Chen H, Liu S, Ji L, Wu T, Ji Y, Zhou Y, Zheng M, Zhang M, Xu W and Huang G: Folic acid supplementation mitigates Alzheimer's disease by reducing inflammation: A randomized controlled trial. Mediators Inflamm. 2016:59121462016. View Article : Google Scholar : PubMed/NCBI
31	Kou S, Zheng Q, Wang Y, Zhao H, Zhang Q, Li M, Qi F, Fang L, Liu L, Ouyang J, et al: Zuo-Gui and You-Gui pills, two traditional Chinese herbal formulas, downregulated the expression of NogoA, NgR, and RhoA in rats with experimental autoimmune encephalomyelitis. J Ethnopharmacol. 158:102–112. 2014. View Article : Google Scholar : PubMed/NCBI
32	Wang YZ, Kou S, Gu LY, Zheng Q, Li M, Qi F, Zhao H and Wang L: Effects of Zuogui Pill () and Yougui Pill () on the expression of brain-derived neurotrophic factor and cyclic adenosine monophosphate/protein kinase A signaling transduction pathways of axonal regeneration in model rats with experimental autoimmune encephalomyelitis. Chin J Integr Med. 20:24–30. 2014. View Article : Google Scholar : PubMed/NCBI
33	Bracegirdle S: The effects of Zuo-gui pills on SOD and MDA of AD model mice. Chin Arch Tradit Chin Med. 2583–2585. 2010.(In Chinese).
34	Engedal K, Barca ML, Laks J and Selbaek G: Depression in Alzheimer's disease: Specificity of depressive symptoms using three different clinical criteria. Int J Geriatr Psychiatry. 26:944–951. 2011. View Article : Google Scholar : PubMed/NCBI
35	Benoit M, Berrut G, Doussaint J, Bakchine S, Bonin-Guillaume S, Frémont P, Gallarda T, Krolak-Salmon P, Marquet T, Mékiès C, et al: Apathy and depression in mild Alzheimer's disease: A cross-sectional study using diagnostic criteria. J Alzheimers Dis. 31:325–334. 2012. View Article : Google Scholar : PubMed/NCBI
36	Souza LC, Jesse CR, Del Fabbro L, de Gomes MG, Goes ATR, Filho CB, Luchese C, Pereira AAM and Boeira SP: Swimming exercise prevents behavioural disturbances induced by an intracerebroventricular injection of amyloid-β_1-42 peptide through modulation of cytokine/NF-kappaB pathway and indoleamine-2,3-dioxygenase in mouse brain. Behav Brain Res. 331:1–13. 2017. View Article : Google Scholar : PubMed/NCBI
37	Souza LC, Jesse CR, Antunes MS, Ruff JR, de Oliveira Espinosa D, Gomes NS, Donato F, Giacomeli R and Boeira SP: Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1–42 peptide in mice. Brain Behav Immun. 56:363–377. 2016. View Article : Google Scholar : PubMed/NCBI
38	Guo J, Chang L, Li C, Li M, Yan P, Guo Z, Wang C, Zha Q and Wang Q: Sb203580 reverses memory deficits and depression-like behavior induced by microinjection of Aβ_1-42 into hippocampus of mice. Metab Brain Dis. 32:57–68. 2017. View Article : Google Scholar : PubMed/NCBI
39	Song X, Liu B, Cui L, Zhou B, Liu W, Xu F, Hayashi T, Hattori S, Ushiki-Kaku Y, Tashiro SI and Ikejima T: Silibinin ameliorates anxiety/depression-like behaviors in amyloid β-treated rats by upregulating BDNF/TrkB pathway and attenuating autophagy in hippocampus. Physiol Behav. 179:487–493. 2017. View Article : Google Scholar : PubMed/NCBI
40	Dai R, Zhang S, Duan W, Wei R, Chen H, Cai W, Yang L and Wang Q: Enhanced autophagy contributes to protective effects of GM1 ganglioside against Aβ1-42-induced neurotoxicity and cognitive deficits. Neurochem Res. 42:2417–2426. 2017. View Article : Google Scholar : PubMed/NCBI
41	Gong G, Yin L, Yuan L, Sui D, Sun Y, Fu H, Chen L and Wang X: Ganglioside GM1 protects against high altitude cerebral edema in rats by suppressing the oxidative stress and inflammatory response via the PI3K/AKT-Nrf2 pathway. Mol Immunol. 95:91–98. 2018. View Article : Google Scholar : PubMed/NCBI
42	Jin W, Xu X, Chen X, Qi W, Lu J, Yan X, Zhao D, Cong D, Li X and Sun L: Protective effect of pig brain polypeptides against corticosterone-induced oxidative stress, inflammatory response, and apoptosis in PC12 cells. Biomed Pharmacother. 115:1088902019. View Article : Google Scholar : PubMed/NCBI
43	Zeng Z, Xu J and Zheng W: Artemisinin protects PC12 cells against β-amyloid-induced apoptosis through activation of the ERK1/2 signaling pathway. Redox Biol. 12:625–633. 2017. View Article : Google Scholar : PubMed/NCBI
44	Wang YL, Wang ZW and Song W: Set up Alzheimer's disease cell apoptosis model with PC-12 cell induced by Aβ(25–35). J Nanjing Med Univ. 208–214. 2003.(In Chinese).
45	Lee S, Youn K and Jun M: Major compounds of red ginseng oil attenuate Aβ_25-35-induced neuronal apoptosis and inflammation by modulating MAPK/NF-κB pathway. Food Funct. 9:4122–4134. 2018. View Article : Google Scholar : PubMed/NCBI
46	Liu H, Deng Y, Gao J, Liu Y, Li W, Shi J and Gong Q: Sodium hydrosulfide attenuates beta-amyloid-induced cognitive deficits and neuroinflammation via modulation of MAPK/NF-κB pathway in rats. Curr Alzheimer Res. 12:673–683. 2015. View Article : Google Scholar : PubMed/NCBI